John C.k. Milligan IV, Secretary/CEO of subsidiary at TherapeuticsMD, Inc. (TXMD), sold 44,252 shares at $1.04 ($46K) on 2021-05-11, disclosed to the SEC on 2021-05-12.
Open-market sale of $46k TXMD by Secretary/CEO of subsidiary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TXMD | BUY | 2019-08-14 | $47K | — | Filing → |
| TXMD | SELL | 2018-12-19 | $1.4M | — | Filing → |
| TXMD | SELL | 2018-12-06 | $1.2M | — | Filing → |